Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma

NCT02110134 is registered in ClinicalTrials.gov with Cynosure, Inc. as lead sponsor.

NCT NCT02110134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02110134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma
Lead sponsor
Cynosure, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
May 31, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma